These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1169 related articles for article (PubMed ID: 34368648)

  • 1. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.
    Park JG; Oladunni FS; Rohaim MA; Whittingham-Dowd J; Tollitt J; Hodges MDJ; Fathallah N; Assas MB; Alhazmi W; Almilaibary A; Iqbal M; Chang P; Escalona R; Shivanna V; Torrelles JB; Worthington JJ; Jackson-Jones LH; Martinez-Sobrido L; Munir M
    iScience; 2021 Sep; 24(9):102941. PubMed ID: 34368648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
    Warner BM; Santry LA; Leacy A; Chan M; Pham PH; Vendramelli R; Pei Y; Tailor N; Valcourt E; Leung A; He S; Griffin BD; Audet J; Willman M; Tierney K; Albietz A; Frost KL; Yates JGE; Mould RC; Chan L; Mehrani Y; Knapp JP; Minott JA; Banadyga L; Safronetz D; Wood H; Booth S; Major PP; Bridle BW; Susta L; Kobasa D; Wootton SK
    iScience; 2021 Nov; 24(11):103219. PubMed ID: 34632328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
    Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
    bioRxiv; 2022 Dec; ():. PubMed ID: 36561185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
    Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters.
    de Swart RL; de Leeuw OS; Oreshkova N; Gerhards NM; Albulescu IC; Vreman S; Gonzales JL; Maas R; van Kuppeveld FJM; Soema P; Bosch BJ; Peeters BPH
    Vaccine; 2022 Aug; 40(33):4676-4681. PubMed ID: 35820941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
    Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
    Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
    Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.
    Díaz MF; Calderón K; Rojas-Neyra A; Vakharia VN; Choque-Guevara R; Montalvan-Avalos A; Poma-Acevedo A; Rios-Matos D; Agurto-Arteaga A; Cauti-Mendoza MG; Perez-Martinez N; Isasi-Rivas G; Tataje-Lavanda L; Sernaque-Aguilar Y; Ygnacio F; Criollo-Orozco M; Huaccachi-Gonzalez E; Delgado-Ccancce E; Villanueva-Pérez D; Montesinos-Millán R; Gutiérrez-Manchay K; Pauyac-Antezana K; Ramirez-Ortiz I; Quiñones-Garcia S; Cauna-Orocollo Y; Vallejos-Sánchez K; Rios-Angulo A; Núñez-Fernández D; Salguedo-Bohorquez MI; Ticona J; Fernández-Sánchez M; Icochea E; Guevara-Sarmiento LA; Zimic M;
    Sci Rep; 2022 Jun; 12(1):10359. PubMed ID: 35725862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
    He L; Zhong J; Li G; Lin Z; Zhao P; Yang C; Wang H; Zhang Y; Yang X; Wang Z
    J Med Virol; 2023 Jan; 95(1):e28237. PubMed ID: 36258299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
    Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
    bioRxiv; 2021 Jan; ():. PubMed ID: 33532770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques.
    Hassan AO; Feldmann F; Zhao H; Curiel DT; Okumura A; Tang-Huau TL; Case JB; Meade-White K; Callison J; Chen RE; Lovaglio J; Hanley PW; Scott DP; Fremont DH; Feldmann H; Diamond MS
    Cell Rep Med; 2021 Apr; 2(4):100230. PubMed ID: 33754147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.
    Ohtsuka J; Imai M; Fukumura M; Maeda M; Eguchi A; Ono R; Maemura T; Ito M; Yamayoshi S; Kataoka Y; Kawaoka Y; Nosaka T
    iScience; 2021 Dec; 24(12):103379. PubMed ID: 34805782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens.
    DiNapoli JM; Kotelkin A; Yang L; Elankumaran S; Murphy BR; Samal SK; Collins PL; Bukreyev A
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9788-93. PubMed ID: 17535926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
    Sun W; Leist SR; McCroskery S; Liu Y; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; García-Sastre A; Krammer F; Baric RS; Palese P
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.
    Sun W; McCroskery S; Liu WC; Leist SR; Liu Y; Albrecht RA; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; Innis BL; García-Sastre A; Krammer F; Baric RS; Palese P
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33348607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
    Agbayani G; Akache B; Renner TM; Tran A; Stuible M; Dudani R; Harrison BA; Duque D; Bavananthasivam J; Deschatelets L; Hemraz UD; Régnier S; Durocher Y; McCluskie MJ
    Eur J Immunol; 2024 Jun; 54(6):e2350620. PubMed ID: 38561974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters.
    Mehla R; Kokate P; Bhosale SR; Vaidya V; Narayanan S; Shandil RK; Singh M; Rudramurthy GR; Naveenkumar CN; Bharathkumar K; Coleman R; Mueller S; Dhere RM; Yeolekar LR
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
    Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
    Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.
    Warner BM; Yates JGE; Vendramelli R; Truong T; Meilleur C; Chan L; Leacy A; Pham PH; Pei Y; Susta L; Wootton SK; Kobasa D
    NPJ Vaccines; 2024 May; 9(1):90. PubMed ID: 38782986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
    Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
    mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.